Introduction {#s01}
============

The CLCs form a widespread family of ion channels and transporters. Although all family homologues mediate the transmembrane movement of anions across biological membranes, the two subclasses do so in mechanistically opposite ways: the channels mediate the passive passage of ions down an electrochemical gradient, whereas the transporters harness the energy stored in a H^+^ gradient to drive anion accumulation, or vice versa. Mutations in at least five of the nine CLC human genes cause genetically inherited disorders such as myotonia congenita, Dent's disease, Barter syndrome, and osteopetrosis ([@bib13]). These hereditary diseases shed light on the ubiquitous roles played by the CLC family members in physiology, from maintaining membrane potential to regulating transepithelial salt transport and controlling intravesicular pH.

The structures of several prokaryotic and eukaryotic homologues define the overall CLC architecture: they are double-barreled homodimers, with each monomer forming independent ion permeation pathways ([@bib9]). The anion permeation pathway is defined by three binding sites ([Fig. 1 A](#fig1){ref-type="fig"}) and is lined by the side chains of a triad of highly conserved residues: a glutamic acid, Glu~ex~, which occludes the pathway toward the extracellular side, a serine, Ser~cen~, and a tyrosine, Tyr~cen~, which constrict the pathway toward the intracellular side ([Fig. 1 A](#fig1){ref-type="fig"}). In the *Escherichia coli* homologue CLC-ec1, Glu~ex~ occupies the external binding site, S~ext~, while the central and internal sites, S~cen~ and S~int~, are occupied by Cl^−^ ions ([@bib9], [@bib10]). When Glu~ex~ is mutated to glutamine or becomes protonated, it moves out of the pathway, and all sites are occupied by Cl^−^ ions ([@bib10]). The structure of the eukaryotic homologue cmCLC, from the thermophilic alga *Cyanidioschyzon merolae* ([@bib12]), revealed a third conformation of the pathway, where Glu~ex~ occupies S~cen~ while S~int~ and S~ext~ are occupied by Cl^−^ ions ([Fig. 1 A](#fig1){ref-type="fig"}). The rearrangements of Glu~ex~ guided the design of numerous functional tests and resulted in the proposal of several hypotheses for the transport mechanism of the CLCs ([@bib17]; [@bib2]; [@bib12]; [@bib6]; [@bib14]).

All models proposed so far share two key assumptions: that all crystallographic states are part of the transport cycle and that the constriction formed by Tyr~cen~ and Ser~cen~ rate limits ion movement between S~cen~ and S~int~ ([@bib17]; [@bib12]; [@bib6]; [@bib14]). Although extensive structure--function studies showed that the two states identified in CLC-ec1 are part of the CLC gating cycle, there is no evidence that a cmCLC-like state occurs during the exchange cycle. Several lines of evidence, stemming from computational ([@bib8]) and experimental work on CLC channels ([@bib20]) and transporters ([@bib24]), suggest that Glu~ex~ can occupy the central cavity. However, in the CLC-0 and -1 channels, interactions between Glu~ex~ and Tyr~cen~ were proposed to occur ([@bib7]) during the common gating process rather than during gating of the individual pores, as would be expected if this state occurred during the transport cycle. Therefore, the issue of whether a cmCLC-like state is part of the exchange cycle remains an open question. Here, we investigate how the activity of CLC-ec1 depends on \[Cl^−^\] and find that the transport activity of CLC-ec1 decreases when S~int~ and S~ext~ become saturated by Cl^−^ ions and trap Glu~ex~ in S~cen~, suggesting that during transport, CLC-ec1 adopts a cmCLC-like conformation.

Materials and methods {#s02}
=====================

Protein purification {#s03}
--------------------

Expression and purification of WT and mutant CLC-ec1 was performed according to published protocols ([@bib3], [@bib4], [@bib5]). In some preparations, the detergent was exchanged from 5 mM DM (*n*-decyl-β-[d]{.smallcaps}-maltopyranoside) to 1 mM DMNG (2,2-dioctylpropane-1,3-bis-β-[d]{.smallcaps}-maltopyranoside). The eluted protein was run on a column (Superdex 200; GE Healthcare) preequilibrated in 100 mM NaCl, 20 mM HEPES, and 5 mM DM or 50 µM DMNG, pH 7.5 (buffer B), for liposome reconstitution and crystallography.

Liposome reconstitution {#s04}
-----------------------

*E. coli* polar lipids (Avanti Polar Lipids, Inc.) were dried under N~2~, resuspended in pentane, and dried again. The dry lipids were suspended to a final concentration of 20 mg/ml in reconstitution buffer (buffer R): 300 mM KCl and 25 mM citric acid, adjusted to pH 7.0, with NaOH, to which 35 mM 3-\[(3-cholamidopropyl)dimethylammonio\]-1-propanesulfonate was added. The suspension was sonicated to clarity, and after a 1--2-h incubation, the purified protein was added to a 5-µg protein/milligram lipid ratio. Detergent was dialyzed out overnight in the desired buffer, and the resulting liposomes were fast frozen in ethanol/dry ice and stored at −80°C. For H^+^ transport, experiments in symmetrical Cl^−^ liposomes were dialyzed in 0--1,000 mM KCl, 0--500 mM K~2~SO~4~, and 50 mM citric acid, pH 4.5, with \[KCl\] + 2\[K~2~SO~4~\] = 1,000. The external solution contained 1 mM KCl, 1 mM glutamic acid, 0--1,000 mM NaCl, and 0--500 mM Na~2~SO~4~, pH 4.5, with \[NaCl\] + 2\[Na~2~SO~4~\] = 1,000.

H^+^ fluxes {#s05}
-----------

H^+^ flux measurements were performed as described previously ([@bib1]; [@bib21]; [@bib6]). In brief, H^+^ influx was initiated by the addition of 1 µl of 1 mg/ml of the K^+^ ionophore valinomycin, which plays a dual role: it shunts the voltage established by the Cl^−^ gradient and sets the membrane potential to the K^+^ equilibrium potential. The time course of H^+^ fluxes was monitored using a pH meter. H^+^ influx was terminated by the addition of 1 µl of 1 mg/ml of the H^+^ ionophore carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone.

^36^Cl^−^ efflux {#s06}
----------------

Proteoliposomes were reconstituted with WT or E148A CLC-ec1 at a 1.5 µg/mg protein/lipid ratio in buffer containing 300 or 1,000 mM KCl, 25 mM citric acid, and 25 mM K~2~HPO~4~, pH 4.5, with NaOH. The external solution was exchanged by spinning the liposomes through a G-50 column preswollen in 400 or 1,000 mM sorbitol, 25 mM citric acid, and 25 mM K~2~HPO~4~, pH 4.5, with NaOH. Uptake of ^36^Cl^−^ was initiated by the addition of 5 µl of a 0.1-µCi/µl Na^36^Cl solution. Efflux was initiated by the addition of one third of the total volume of a stock solution containing 900 or 3,000 mM KCl, 25 mM citric acid, and 25 mM K~2~HPO~4~, pH 4.5, with NaOH. Individual efflux time courses were fitted to a decreasing single exponential function of the form *C*(*t*) = *C~0~* + *A* · exp(−*t*/τ), where *C*(*t*) represents the fractional counts at time *t*, *C~0~* is the equilibrium fraction of trapped radioactivity, *t* is time, and τ is the time constant of efflux. Individual time courses were normalized to the maximum counts to yield the normalized uptake and averaged among different experiments.

Results {#s07}
=======

Trapping Glu~ex~ in the central binding site {#s08}
--------------------------------------------

Our first goal is to determine whether the cmCLC filter conformation where Glu~ex~ in S~cen~ is "sandwiched" between two Cl^−^ ions in S~int~ and S~ext~ is part of the conformational cycle of the CLC transporters. If this were the case, transport of these exchangers should have a bell-shaped dependence on Cl^−^ concentration, with the initial rise in activity caused by the increased substrate availability and the subsequent decrease to the trapping of Glu~ex~ between the fully occupied S~ext~ and S~int~. To test this hypothesis, we monitored the activity of WT CLC-ec1 by measuring H^+^ transport as a function of \[Cl^−^\] while maintaining the pH and \[Cl^−^\] symmetry ([Fig. 1 B](#fig1){ref-type="fig"}). Transport was driven by a negative potential inside the liposomes generated by the application of the K^+^ ionophore valinomycin in the presence of a 300-fold K^+^ gradient, V(K^+^) ≅ −177 mV, which promotes H^+^ influx and Cl^−^ efflux. As expected, in the absence of Cl^−^, there is no transport. As \[Cl^−^\] is raised symmetrically, H^+^ transport increases and peaks at ∼300 mM \[Cl^−^\]. However, instead of plateauing at its maximum, at \[Cl^−^\] \> 300 mM, H^+^ transport decreases to ∼35% of its maximal value at 1 M \[Cl^−^\] ([Fig. 1, C and D](#fig1){ref-type="fig"}).

![**Cl^−^-driven trapping of Glu~ex~ in S~cen~.** (A) Close-up view of the Cl^−^-binding site in cmCLC. The numbering of Glu~ex~, Ser~cen~, and Tyr~cen~ corresponds to CLC-ec1. Green spheres are the Cl^−^ ions. (B) Schematic representation of the trapping experiments. (C) Normalized time course of H^+^ transport mediated by CLC-ec1 in the presence of 70, 300, 500, 750, or 1,000 mM symmetrical \[Cl^−^\]. The asterisk denotes the addition of valinomycin to initiate the experiment. The dashed line represents an exponential fit of the time courses. Bar, 10 s. (D) Mean steady-state H^+^ uptake in 1--1,000 mM symmetrical \[Cl^−^\] normalized to the value in 300 mM Cl. Values are reported in [Table 1](#tbl1){ref-type="table"}; error bars are the SEM of the number of experiments indicated in [Table 1](#tbl1){ref-type="table"}.](JGP_201611682_Fig1){#fig1}

###### Cl^−^ dependence of the activity of CLC-ec1 measured by H^+^ transport

  **Protein**   **\[Cl^−^\]**   **\[H\]/\[H\]~300Cl~**   ***n***
  ------------- --------------- ------------------------ ---------
                *mM*                                     
  WT CLC-ec1    0               0.013 ± 0.001            3
                50              0.30 ± 0.03              7
                70              0.46 ± 0.02              17
                100             0.76 ± 0.03              3
                150             0.86 ± 0.01              3
                300             1.00 ± 0.02              29
                500             0.90 ± 0.04              23
                750             0.73 ± 0.06              14
                1,000           0.35 ± 0.03              16
  S107A         70              0.31 ± 0.01              8
                300             1.00 ± 0.03              11
                500             1.57 ± 0.37              11
                750             0.89 ± 0.12              11
                1,000           0.27 ± 0.03              8
  Y445F         70              0.44 ± 0.02              9
                300             1.00 ± 0.06              9
                500             1.36 ± 0.06              10
                750             0.73 ± 0.09              10
                1,000           0.27 ± 0.06              8
  S107A/Y445F   0               0.012 ± 0.001            3
                70              0.63 ± 0.06              11
                300             1.00 ± 0.05              8
                500             1.13 ± 0.11              11
                750             1.07 ± 0.13              11
                1,000           0.40 ± 0.05              10

Data are reported as the mean ± SEM of *n* experiments from two to eight independent preparations.

The simplest interpretation of these results is that at high salt concentrations, Glu~ex~ becomes trapped between the saturated S~int~ and S~ext~ sites. However, alternative explanations exist. For example, saturation of only one site could be sufficient to inhibit transport. This could either be S~int~, which has a low equilibrium affinity for Cl^−^ ([@bib15]; [@bib18]), or an allosteric site outside the pathway, such as the computationally proposed S~ext~\* site ([@bib11]; [@bib22]). If the high salt inhibition reflects trapping of Glu~ex~, introduction of the E148A mutation should abolish it. However, because this mutant does not transport H^+^ ([@bib1]), we used an independent approach to test this hypothesis ([Fig. 2 A](#fig2){ref-type="fig"}). We prepared proteoliposomes with 300 or 1,000 mM internal Cl^−^ and loaded them with ^36^Cl^−^ under uptake conditions ([Fig. 2 A](#fig2){ref-type="fig"}, left; [@bib16]). After waiting 15 min to let the uptake reaction reach steady state ([@bib19]), we added 300 or 1,000 mM Cl^−^ to the external solution to annul the electrochemical gradient driving ^36^Cl^−^ accumulation and release the accumulated radioisotope ([Fig. 2 A](#fig2){ref-type="fig"}, right). In liposomes reconstituted with WT CLC-ec1 at 300 mM Cl^−^, efflux occurs with a time constant of τ^WT^(300 Cl) ≅ 1.1 min ([Fig. 2, B and C](#fig2){ref-type="fig"}). When the Cl^−^ concentration is raised symmetrically to 1,000 mM, efflux slows down approximately threefold to τ^WT^(1,000 Cl) ≅ 3.2 min ([Fig. 2, B and C](#fig2){ref-type="fig"}), in excellent agreement with the near threefold reduction in activity seen between the 300 and 1,000 mM Cl^−^ conditions in the H^+^ transport measurements ([Fig. 1 D](#fig1){ref-type="fig"}). The inhibition is abolished in liposomes reconstituted with the E148A mutant ([Fig. 2, B and C](#fig2){ref-type="fig"}): ^36^Cl^−^ efflux occurs with similar kinetics regardless of the salt concentrations (τ^E148A^(300 Cl) ≅ 12.3 min and τ^E148A^(1,000 Cl) ≅ 14.5 min). These results suggest that the high salt inhibition does not reflect saturation of a single Cl^−^-binding site, as in the E148A mutant, all sites can be occupied by ions but no decrease in activity is observed at maximal salt concentrations. Rather, our findings show that removal of the Glu~ex~ side chain is sufficient to abolish the high salt inhibition of transport, consistent with the hypothesis that this phenomenon reflects the trapping of Glu~ex~ between two fully occupied binding sites. It is interesting to note that efflux by E148A CLC-ec1 is ∼12-fold slower than that mediated by the WT transporter, consistent with the increased Cl^−^ binding affinity of this mutant when measured in equilibrium conditions ([@bib18]).

![**Mutation of Glu~ex~ relieves the high salt inhibition.** (A) Schematic representation of the ^36^Cl^−^ efflux experiments. (B and C) Time course of ^36^Cl^−^ efflux from proteoliposomes reconstituted with WT CLC-ec1 at 300 mM Cl^−^ or at 1,000 mM Cl^−^ or with the E148A mutant at 300 mM Cl^−^ or at 1,000 mM Cl^−^. Solid lines represent exponential fits of the time courses with time constants (shown in C) of τ^WT^(300 Cl) = 1.15 ± 0.18 min, τ^WT^(1,000 Cl) = 3.12 ± 0.32 min, τ^E148A^ (300 Cl) = 12.3 ± 0.5 min, and τ^E148A^(1,000 Cl) = 14.5 ± 1.4 min. Symbols represent the mean from four independent experiments, and the error bars are the SEM.](JGP_201611682_Fig2){#fig2}

Hydrogen bonds stabilize Glu~ex~ in the central site {#s09}
----------------------------------------------------

Although consistent with our results, it remains to be demonstrated that the state stabilized by high Cl^−^ is the one where Glu~ex~ occupies S~cen~ while S~int~ and S~ext~ are simultaneously occupied by Cl^−^ ions. In the cmCLC structure, Glu~ex~ is within hydrogen bonding distance of the hydroxyls from Ser~cen~ and Tyr~cen~ ([Fig. 1 A](#fig1){ref-type="fig"}), which correspond to S107 and Y445 in CLC-ec1. Therefore, we tested whether Glu~ex~ forms hydrogen bonds with either or both residues and how elimination of either hydroxyl moiety affects trapping. If the interactions between Glu~ex~, Ser~cen~, and Tyr~cen~ stabilize the sandwiched state, their disruption should make the trapping more difficult. This is the case; the Cl^−^ dependence of the activity of the S107A ([Fig. 3, A and B](#fig3){ref-type="fig"}) and Y445F ([Fig. 3, C and D](#fig3){ref-type="fig"}) mutants has the same bell shape as seen for the WT protein, but the peak is shifted to ∼500 mM \[Cl^−^\], indicating that more Cl^−^ is required to trap Glu~ex~ in S~cen~. When both hydroxyls are removed in the S107A/Y445F double mutant, the peak broadens and activity begins to decrease only at \[Cl^−^\] ≥ 750 mM ([Fig. 3, E and F](#fig3){ref-type="fig"}). These results suggest that during the exchange cycle, Glu~ex~ does form hydrogen bonds with both Ser~cen~ and Tyr~cen~ and that these interactions together with the Cl^−^ occupancy of S~int~ and S~ext~ stabilize Glu~ex~ in the S~cen~ site. Alternatively, these results could also reflect weakened Cl^−^ binding to S~int~ as a result of the mutations. However, this is unlikely to be the case, as these constructs mediate robust H^+^ transport, unlike the mutants at these positions that weaken ion binding ([@bib5]; [@bib21]; [@bib23]) but like the Y445F mutant that does not affect ion binding ([@bib5]). Interestingly, in low \[Cl^−^\], the relative activity of the double mutant is higher than that of the WT or single mutants ([Fig. 3, B, D, and F](#fig3){ref-type="fig"}), suggesting that these interactions might also play a role in other states visited by the transporter during the exchange cycle.

![**Hydrogen bonds stabilize Glu~ex~ in the central site.** (A and B) Normalized time course of H^+^ transport (A) and mean normalized steady-state H^+^ uptake (B) mediated by the S107A mutant in varying symmetrical \[Cl^−^\]. (C and D) Normalized time course of H^+^ transport (C) and mean normalized steady-state H^+^ uptake (D) mediated by the Y445F mutant in varying symmetrical \[Cl^−^\]. (E and F) Normalized time course of H^+^ transport (E) and mean normalized steady-state H^+^ uptake (F) mediated by the S107A/Y445F double mutant in varying symmetrical \[Cl^−^\]. The asterisks denote the addition of valinomycin to initiate the experiment. Dashed lines represent exponential fits of the time courses. Bars, 10 s. The values are reported in [Table 1](#tbl1){ref-type="table"}; error bars are the SEM of the number of experiments indicated in [Table 1](#tbl1){ref-type="table"}.](JGP_201611682_Fig3){#fig3}

Discussion {#s10}
==========

Despite recent advances, the mechanism by which the CLC transporters catalyze the exchange of two Cl^−^ for one H^+^ remains poorly understood. Combined crystallographic, functional, and computational studies have led to the proposal of several models ([@bib17]; [@bib12]; [@bib6]; [@bib14]) that, however, fail to capture all key features of these transporters. The crystal structures of WT and mutant CLC-ec1 and cmCLC suggested that a conserved glutamic acid, Glu~ex~, can adopt three conformations ([@bib9], [@bib10]; [@bib12]) and that the interconversion of this side chain between these states underlies H^+^/Cl^−^ exchange. In the structure of cmCLC, Glu~ex~ occupies the central binding site and is trapped by two Cl^−^ ions in the internal and external sites ([Fig. 1 A](#fig1){ref-type="fig"}). The existence of such a state in other CLC homologues, however, has not been demonstrated. Here, we show that during transport, CLC-ec1, the prototypical CLC exchanger, visits a conformation whose functional characteristics closely match those predicted for a cmCLC-like state. We find that the activity of CLC-ec1 has a biphasic dependence on \[Cl^−^\]; it increases monotonically between 0 and 500 mM Cl^−^ and then decreases, rather than plateauing as expected for a transporter that reaches substrate saturation. This decrease in activity is consistent with the idea that during transport, Glu~ex~ can reside in S~cen~, so that when both S~int~ and S~ext~ are occupied by ions at very high chloride concentrations, it becomes trapped in a cmCLC-like state. This hypothesis is further corroborated by the finding that disrupting the hydrogen bonds that stabilize Glu~ex~ in S~cen~ by mutating Tyr~cen~ and Ser~cen~ destabilizes the trapped state.

Our results, in good agreement with past work ([@bib15]; [@bib18]), suggest that at least one of the binding sites of CLC-ec1, presumably S~int~, has very low affinity for Cl^−^. However, in our measurements, the inhibition of CLC-ec1---which we hypothesize reflects the saturation of S~int~---only manifests itself at Cl^−^ concentrations \>500 mM, whereas the isothermal titration calorimetry and crystallographic experiments placed the affinity of S~int~ in the 20--40-mM range. Although we do not have a definitive explanation for the discrepancy, we speculate that two issues mitigate this inconsistency. First, our experiments were performed during active transport and in the presence of a large applied voltage that varies during the course of the experiment. The presence of a large transbilayer voltage could affect the apparent Cl^−^ affinity directly, as ions traverse different fractions of the electric field to reach the three binding sites, and indirectly, as the coupled movement of ions and of the Glu~ex~ side chain within the pore occurs within the electric field. In contrast, the isothermal titration calorimetry and crystallographic measurements were performed in equilibrium conditions and in the absence of an applied voltage. Second, the lack of orientation in our reconstitutions prevented us from extracting the apparent affinity of Cl^−^ for the two sites, as the voltage used to drive transport has opposite effects on ion binding depending on the directionality of the insertion of CLC-ec1 in the liposomal membrane. It is worth noting that the affinity of the S~ext~ site is too low to be detected in our experiments, as the lowest \[Cl^−^\] tested is 50 mM, at which point this site would be fully saturated ([@bib18]). At present, the concentrations at which the affinity of this site would be resolved are below our signal to noise detection limit. Collectively, our results suggest that during CLC gating, Glu~ex~ can occupy both S~ext~ and S~cen~ and that its interactions with Tyr~cen~ and Ser~cen~ contribute to the determination of the equilibrium between these two conformations.
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